WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 407438

CAS#: 1005264-47-0

Description: MX69 is a Dual Inhibitor of MDM2 and XIAP for Cancer Treatment.

Price and Availability

Size Price Shipping out time Quantity
100mg USD 1050 2 Weeks
200mg USD 1750 2 Weeks
500mg USD 2450 2 Weeks
1g USD 3250 2 Weeks
2g USD 4850 2 Weeks
5g USD 8250 2 Weeks
Inquire bulk and customized quantity

Pricing updated 2021-01-18. Prices are subject to change without notice.

MX69, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.

Chemical Structure


Theoretical Analysis

MedKoo Cat#: 407438
Name: MX69
CAS#: 1005264-47-0
Chemical Formula: C27H26N2O4S
Exact Mass: 474.1613
Molecular Weight: 474.575
Elemental Analysis: C, 68.33; H, 5.52; N, 5.90; O, 13.48; S, 6.76

Synonym: MX69; MX-69; MX 69.

IUPAC/Chemical Name: 4-(8-(N-(2,3-dimethylphenyl)sulfamoyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-4-yl)benzoic acid


InChi Code: InChI=1S/C27H26N2O4S/c1-16-5-3-8-24(17(16)2)29-34(32,33)20-13-14-25-23(15-20)21-6-4-7-22(21)26(28-25)18-9-11-19(12-10-18)27(30)31/h3-6,8-15,21-22,26,28-29H,7H2,1-2H3,(H,30,31)

SMILES Code: O=S(C1=CC2=C(NC(C3=CC=C(C(O)=O)C=C3)C4C2C=CC4)C=C1)(NC5=C(C)C(C)=CC=C5)=O

Technical Data

Solid powder

>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:


1: Gu L, Zhang H, Liu T, Zhou S, Du Y, Xiong J, Yi S, Qu CK, Fu H, Zhou M.
Discovery of Dual Inhibitors of MDM2 and XIAP for Cancer Treatment. Cancer Cell.
2016 Oct 10;30(4):623-636. doi: 10.1016/j.ccell.2016.08.015. Epub 2016 Sep 22.
PubMed PMID: 27666947; PubMed Central PMCID: PMC5079537.